No Data
No Data
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 From $71 at JPMorgan
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
Express News | Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Addus Homecare (ADUS) and Cytokinetics (CYTK)
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $53